ReviewCardiovascular diabetology2017

Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.

Jean-Charles FruchartPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.